Washington, DC—For the first time in decades, the federal government has begun paying private insurers to provide care for adults with cancer.
The Centers for Medicare and Medicaid Services (CMS) will pay $1.9 billion over 10 years to two new companies that specialize in diagnosing and treating acute illnesses.
But these new companies will be paid for by the government.
“We’re looking for providers that are in a unique geographic area, and we want them to be able to access our infrastructure,” said Dr. David J. M. Oderberg, the acting administrator of CMS.
“There are a lot of providers that have to move to new places, and they can’t afford to go.”
The new companies, called COVID-19 Provider Network (PNP) and COVID Treatment Network (CTN), are part of the agency’s “pre-funding” program, which will reimburse private health insurers up to $200 million to provide services for people diagnosed with COVID, the most deadly form of pneumonia.
“These new providers are really going to be the first to be paid,” Oderber said.
A $100 million cap will help cover the cost of administering the new programs, but there will be no limits on how many providers will be offered.
Private insurers already have access to a growing number of doctors and hospitals, including some in California, where nearly half of the new patients will come from.
This means that a patient will be able get the care she or he needs even if it is not at the local or state level.
A growing number health care providers, including the Centers for Disease Control and Prevention (CDC), have been working to develop new ways to pay for care for chronic conditions, including cancer.
“What we have now is a very, very small fraction of providers, maybe one percent or two percent, that have been doing this for a long time,” said Robert B. Bauers, a professor of health economics at Duke University who has been studying the use of pre-funding in the United States.
The new payment models are the first in a new series of federal pre-funds designed to help cover costs for chronic illnesses.
While the new payments will provide money for the majority of chronic conditions covered under the Affordable Care Act, the money will not cover all the cost.
The government is also planning to provide a “cap-and-trade” program for carbon dioxide emissions, to limit how much carbon pollution is emitted from existing power plants.
These new caps will be set at a level that is much lower than the current level, and could reduce the cost for some patients.
The first COVID provider network is expected to be established in December, with more expected in the coming months.
A second, larger, program is being established to cover chronic conditions in California.
The two companies are both private, and there is no requirement that they have the same facilities or staff.
The COVID Foundation, a nonprofit that promotes health care for the sick and poor, is coordinating the work.
“It’s going to help these patients get the best care they can get,” said John P. Gorman, president of the foundation.
“If they’re in the same room, they can talk to each other.
They’re all going to get the same care.”
The COVAID Network will be the only new provider network to be funded by the new Medicare payment program, and it will cover about 40 percent of all new COVID treatments in the U.S. It is the only federal payment program that allows doctors to treat chronic conditions at a cost of less than $100 per treatment.
There are about 2.7 million Medicare beneficiaries, including about half of Americans over age 65, who are diagnosed with a chronic disease, according to the Centers For Disease Control.
There is no way to make this money available to private insurers, and some health care plans have said they won’t pay for treatment for COVID patients until there is a national plan in place.
The cost of treatment for some chronic conditions is higher than the cost that could be paid by the federal system.
COVID treatment in California is expected have a higher cost per patient than COVID therapy, because it has fewer hospitals and fewer doctors, said Jennifer Kuchera, chief executive of COVAIDS, a network of doctors, hospitals, and clinics that will be established.
But there are other health care systems that have similar budgets and have also been successful in reducing costs for COVAIDs.
“California is not alone,” Kucchera said.
“The private sector has been able to find efficiencies in their practices and are able to pay more for care.”
COVID medications have a lower mortality rate, according, to the CDC, than standard treatments for COVI.
COVAids has not set a goal for COVD care, but the organization hopes to reduce mortality rates among COVID patient groups.
“Our goal is to make COVID care as efficient